Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety Study of Tivanisiran to Treat Dry Eye

ClinicalTrials.gov ID: NCT05310422

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT05310422. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 19, 2026, 6:01 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will examine the safety of tivanisiran sodium eye drops versus vehicle when dosed once daily for 1 year in subjects with signs and symptoms of dry eye disease (DED).

Study identification

NCT ID
NCT05310422
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sylentis, S.A.
Industry
Enrollment
301 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 24, 2022 (Actual)
Primary completion
Oct 11, 2023 (Actual)
Completion
Oct 11, 2023 (Actual)
Last update posted
Sep 9, 2026

2022 – 2023

United States locations

U.S. sites
25
U.S. states
12
U.S. cities
24
Facility City State ZIP Site status
Sylentis Investigative Site Chandler Arizona 85021 —
Sylentis Investigative Site Phoenix Arizona 85032 —
FYDES Investigative Site Glendale California 91204 —
Sylentis Investigative Site Hemet California 92545 —
Sylentis Investigative Site Los Angeles California 85032 —
Sylentis Investigative Site Murrieta California 92562 —
Sylentis Investigative Site Newport Beach California 92663 —
FYDES Investigative Site Delray Beach Florida 33484 —
FYDES Investigative Site Jacksonville Florida 32256 —
Sylentis Investigative Site Largo Florida 33773 —
Sylentis Investigative Site Morrow Georgia 30260 —
Sylentis Investigative Site Fraser Michigan 48026 —
Sylentis Investigative Site Kansas City Missouri 64111 —
FYDES Investigative Site St Louis Missouri 63131 —
Sylentis Investigative Site Washington Missouri 63090 —
Sylentis Investigative Site Rochester New York 14618 —
Sylentis Investigative Site Asheville North Carolina 28803 —
Sylentis Investigative Site Garner North Carolina 27529 —
Sylentis Investigative Site Cranberry Township Pennsylvania 16066 —
Sylentis Investigative Site Rapid City South Dakota 57701 —
Sylentis Investigative Site Memphis Tennessee 38119 —
Sylentis Investigative Site Austin Texas 78731 —
FYDES Investigative Site El Paso Texas 79902 —
Sylentis Investigative Site San Antonio Texas 78215 —
Sylentis Investigative Site San Antonio Texas 78230 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05310422, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 9, 2026 · Synced Nov 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.